Thrombospondin 1 and thrombospondin 2 (THBS1 and THBS2) share similar multifunctional domains, and are known to be antiangiogenic. However, the expression pattern of THBS1 and THBS2 is different, and
Our aim was to evaluate the expression of chemokines in breast cancers before treatment to identify a molecular signature that could distinguish between women with or without cancer. We identified a p
aClassification of band intensity: -, completely invisible; ±, faintly visible; +, visible; ++, clearly visible; +++, strongly visible.bmiR-126 expression was measured with TaqMan and calculated by th
